India's largest drugs firm, Ranbaxy Laboratories, is withdrawing its HIV medicines from a list approved by the World Health Organisation.
The firm has decided to pull all seven of its anti-retroviral drugs from the WHO list.
Studies failed to prove the generic versions produced by the company were equivalent to the patented drugs.
However, WHO said patients should only stop using the drugs if they could find alternative HIV medication.